Advertisement

Expression of cyclooxygenase-2 in transitional cell carcinoma of the urinary bladder in dogs

View More View Less
  • 1 Searle Research and Development, Skokie, IL 60077.
  • | 2 Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Purdue University, West Lafayette, IN 47907-1248.
  • | 3 Department of Veterinary Pathobiology, School of Veterinary Medicine, Purdue University, West Lafayette, IN 47907-1248.
  • | 4 Searle Research and Development, Skokie, IL 60077.

Abstract

Objective—To evaluate expression of cyclooxygenase (COX)-1 and COX-2 in the urinary bladder epithelium of clinically normal dogs and in transitional cell carcinoma cells of dogs.

Animals—21 dogs with transitional cell carcinoma of the urinary bladder and 8 dogs with clinically normal urinary bladders.

Procedure—COX-1 and COX-2 were evaluated by use of isoform-specific antibodies with standard immunohistochemical methods.

Results—COX-1, but not COX-2, was constitutively expressed in normal urinary bladder epithelium; however, COX-2 was expressed in neoplastic epithelium in primary tumors and in metastatic lesions of all 21 dogs and in new proliferating blood vessels in 3 dogs. Also, COX-1 was expressed in the neoplastic cells.

Conclusions and Clinical Relevance—Lack of expression of COX-2 in normal bladder epithelium and its substantial expression in transitional cell carcinoma cells suggest that this isoform may be involved in tumor cell growth. Inhibition of COX-2 is a likely mechanism of the antineoplastic effects of non steroidal antiinflammatory drugs. (Am J Vet Res 2000;61:478–481)

Abstract

Objective—To evaluate expression of cyclooxygenase (COX)-1 and COX-2 in the urinary bladder epithelium of clinically normal dogs and in transitional cell carcinoma cells of dogs.

Animals—21 dogs with transitional cell carcinoma of the urinary bladder and 8 dogs with clinically normal urinary bladders.

Procedure—COX-1 and COX-2 were evaluated by use of isoform-specific antibodies with standard immunohistochemical methods.

Results—COX-1, but not COX-2, was constitutively expressed in normal urinary bladder epithelium; however, COX-2 was expressed in neoplastic epithelium in primary tumors and in metastatic lesions of all 21 dogs and in new proliferating blood vessels in 3 dogs. Also, COX-1 was expressed in the neoplastic cells.

Conclusions and Clinical Relevance—Lack of expression of COX-2 in normal bladder epithelium and its substantial expression in transitional cell carcinoma cells suggest that this isoform may be involved in tumor cell growth. Inhibition of COX-2 is a likely mechanism of the antineoplastic effects of non steroidal antiinflammatory drugs. (Am J Vet Res 2000;61:478–481)